Zydus Lifesciences Limited — Important, 11-04-2025: General Updates

Zydus Lifesciences Limited has incorporated a wholly owned subsidiary, Zydus MedTech (France) SAS, which is set to acquire a controlling stake of 85.6% in Amplitude Surgical SA, France, for a total consideration of Euro 256.8 million at Euro 6.25 per share. This acquisition will be executed through Zydus MedTech (France) SAS, which has an authorized share capital of Euro 1,000 and is currently not operational. The incorporation strengthens Zydus's strategic footprint in France as it prepares to conduct a cash tender offer for the remaining shares and aim for a compulsory acquisition of minority holdings, which could enhance its market position. The initiative reflects a significant step towards diversifying Zydus's investment portfolio and could create substantial growth opportunities moving forward. Investors should maintain a positive outlook as this development aligns with the company's long-term growth strategy.